Borneol-modified docetaxel plus tetrandrine micelles for treatment of drug-resistant brain glioma
CONCLUSIONS: BO-modified DTX plus TET micelles may provide a new treatment method for drug-resistant brain gliomas.PMID:38235554 | DOI:10.1080/03639045.2024.2302886
Source: Drug Development and Industrial Pharmacy - Category: Drugs & Pharmacology Authors: Yang Liu Jia-Yu Cai Yang Liu Lu Zhang Rui-Bo Guo Xue-Tao Li Ling-Yue Ma Liang Kong Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Chemotherapy | Docetaxel | Drugs & Pharmacology | Glioma | Multidrug Resistance | Neurology | Stem Cell Therapy | Stem Cells | Study | Taxotere